News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
152,200 Results
Type
Article (10460)
Company Profile (3)
Press Release (141737)
Multimedia
Podcasts (20)
Webinars (5)
Section
Business (32530)
Career Advice (257)
Deals (5132)
Drug Delivery (38)
Drug Development (26021)
Employer Resources (43)
FDA (4610)
Job Trends (3472)
News (69592)
Policy (7791)
Tag
Academia (821)
Accelerated approval (12)
Adcomms (4)
Allergies (64)
Alliances (6799)
ALS (36)
Alzheimer's disease (399)
Antibody-drug conjugate (ADC) (121)
Approvals (4792)
Artificial intelligence (97)
Autoimmune disease (67)
Automation (4)
Bankruptcy (34)
Best Places to Work (3130)
BIOSECURE Act (9)
Biosimilars (54)
Biotechnology (2)
Bladder cancer (92)
Brain cancer (15)
Breast cancer (208)
Cancer (1969)
Cardiovascular disease (179)
Career advice (243)
Career pathing (5)
CAR-T (119)
CDC (30)
Celiac Disease (1)
Cell therapy (272)
Cervical cancer (17)
Clinical research (22720)
Collaboration (276)
Compensation (40)
Complete response letters (14)
COVID-19 (719)
CRISPR (37)
C-suite (133)
Cystic fibrosis (49)
Data (2966)
Decentralized trials (2)
Depression (47)
Dermatology (34)
Diabetes (194)
Diagnostics (1753)
Digital health (14)
Diversity (2)
Diversity, equity & inclusion (17)
Drug discovery (42)
Drug pricing (98)
Drug shortages (9)
Duchenne muscular dystrophy (46)
Earnings (14737)
Editorial (29)
Employer branding (4)
Employer resources (40)
Events (28925)
Executive appointments (138)
FDA (5580)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (266)
Gene editing (73)
Generative AI (5)
Gene therapy (167)
GLP-1 (260)
Government (1393)
Grass and pollen (2)
Guidances (120)
Healthcare (5326)
HIV (11)
Huntington's disease (2)
IgA nephropathy (45)
Immunology and inflammation (38)
Immuno-oncology (25)
Indications (57)
Infectious disease (788)
Inflammatory bowel disease (49)
Inflation Reduction Act (7)
Influenza (28)
Intellectual property (46)
Interviews (23)
IPO (2782)
IRA (18)
Job creations (461)
Job search strategy (221)
JPM (12)
Kidney cancer (12)
Labor market (9)
Layoffs (81)
Leadership (8)
Legal (1119)
Liver cancer (26)
Longevity (8)
Lung cancer (260)
Lymphoma (202)
Machine learning (5)
Management (17)
Manufacturing (173)
MASH (68)
Medical device (3138)
Medtech (3177)
Mergers & acquisitions (2531)
Metabolic disorders (426)
mRNA (43)
Multiple sclerosis (35)
NASH (2)
Neurodegenerative disease (57)
Neuropsychiatric disorders (21)
Neuroscience (714)
NextGen: Class of 2026 (1621)
Non-profit (1886)
Now hiring (1)
Obesity (165)
Opinion (72)
Ovarian cancer (63)
Pain (67)
Pancreatic cancer (136)
Parkinson's disease (91)
Partnered (6)
Patents (75)
Patient recruitment (132)
Peanut (25)
People (10721)
Pharmaceutical (2)
Pharmacy benefit managers (15)
Phase 1 (6142)
Phase 2 (9369)
Phase 3 (8468)
Pipeline (2339)
Policy (127)
Postmarket research (1251)
Preclinical (3238)
Press Release (3)
Prostate cancer (115)
Psychedelics (5)
Radiopharmaceuticals (59)
Rare diseases (289)
Real estate (780)
Recruiting (11)
Regulatory (6771)
Reports (9)
Research institute (599)
Resumes & cover letters (18)
Rett syndrome (8)
RNA editing (5)
RSV (22)
Schizophrenia (30)
Series A (38)
Series B (26)
Sickle cell disease (54)
Special edition (8)
Spinal muscular atrophy (32)
Sponsored (6)
Startups (408)
Stomach cancer (2)
Supply chain (25)
Tariffs (39)
The Weekly (20)
Vaccines (288)
Venture capital (18)
Weight loss (99)
Women's health (34)
Worklife (3)
Date
Today (43)
Last 7 days (209)
Last 30 days (876)
Last 365 days (7141)
2026 (2569)
2025 (7135)
2024 (8311)
2023 (9405)
2022 (11111)
2021 (11969)
2020 (11675)
2019 (11695)
2018 (8930)
2017 (6794)
2016 (6660)
2015 (7741)
2014 (5822)
2013 (4539)
2012 (4840)
2011 (5280)
2010 (4937)
Location
Africa (153)
Alabama (54)
Alaska (3)
Arizona (87)
Arkansas (4)
Asia (8001)
Australia (1308)
California (2841)
Canada (696)
China (347)
Colorado (99)
Connecticut (160)
Delaware (128)
Europe (18955)
Florida (419)
Georgia (103)
Hawaii (1)
Idaho (10)
Illinois (310)
India (17)
Indiana (178)
Iowa (7)
Japan (123)
Kansas (23)
Kentucky (11)
Louisiana (17)
Maine (4)
Maryland (476)
Massachusetts (1936)
Michigan (71)
Minnesota (112)
Mississippi (3)
Missouri (47)
Montana (11)
Nebraska (3)
Nevada (39)
New Hampshire (13)
New Jersey (1098)
New Mexico (8)
New York (761)
North Carolina (364)
North Dakota (4)
Northern California (1475)
Ohio (79)
Oklahoma (6)
Oregon (5)
Pennsylvania (503)
Puerto Rico (4)
Rhode Island (6)
South America (293)
South Carolina (59)
Southern California (1107)
Tennessee (46)
Texas (397)
United States (10560)
Utah (61)
Vermont (1)
Virginia (97)
Washington D.C. (32)
Washington State (240)
Wisconsin (30)
152,200 Results for "american geophysical union agu".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
C-suite
JPM26: Filling C-Suites, Union Square—and Elevators—With Pink
Attendance at the Biotech CEO Sisterhood’s annual photo of women leaders and allies in Union Square doubled this year. There’s still more work to do.
January 21, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration
April 22, 2026
·
13 min read
Press Releases
Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union
April 29, 2026
·
5 min read
Government
HHS Will No Longer Recognize Employee Unions
Thousands of employees across the Department of Health and Human Services are set to lose their collective bargaining rights in a move that American Federation of Government Employees national president Everett Kelley called “illegal and immoral.”
August 25, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Trump Calls on Congress To Codify Most Favored Nation Drug Pricing in SOTU
In his State of the Union address on Tuesday evening, President Donald Trump urged Republican leaders to pass legislation cementing his new drug pricing initiatives as he touted his efforts to lower healthcare costs for Americans.
February 25, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union
March 30, 2026
·
4 min read
Press Releases
Lilly’s Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata
March 1, 2026
·
16 min read
Press Releases
Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome
February 27, 2026
·
4 min read
Press Releases
DAWNZERA™ (donidalorsen) approved in the European Union for hereditary angioedema (HAE)
January 21, 2026
·
5 min read
Vaccines
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait
After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out on as other nations embrace the technology.
February 16, 2026
·
3 min read
·
Annalee Armstrong
1 of 15,220
Next
